DOTmed Home MRI Oncology Ultrasound Molecular Imaging X-Ray Cardiology Health IT Business Affairs
News Home Parts & Service Operating Room CT Women's Health Proton Therapy Endoscopy HTMs Mobile Imaging
SEARCH
当前地点:
>
> This Story


注册记数器 to rate this News Story
Forward Printable StoryPrint Comment

 

 

More Magazine Features

The importance of breast MR screening for high-risk patients Experts weigh in on MR's emerging role in breast cancer diagnostics

AI to workflow, breast imaging makes advances A look at the latest innovations reaching the healthcare marketplace

Taking the mystery out of breast density One state at a time, awareness is spreading across the country

The benefits of utilizing teleradiology For some providers, outsourcing image interpretation makes a world of difference

In PET and SPECT, getting more sensitive and working smarter A look at the newest systems on the market

See All Magazine Features  

Oncology Homepage

FDA clears IsoRay's and GT's cesium-131 based brachytherapy Performed during surgery to remove brain tumor, reduces follow-ups

Onkos Surgical and Insight Medical partner to bring augmented reality to tumor surgery Could this become the new standard of care?

Andrew J. Evans and Erik P. Sulman NYU Langone Health hires nationally renowned radiation oncologists

Combined radionuclide therapy and immunotherapy shows promise New research unveiled at SNMMI meeting

RaySearch releases RayStation 8A Offers greater support for radiation, proton and carbon ion therapies

Radiotherapy IT company CruxQS acquires RDS Will expand footprint for FlowBoard workflow management system

New model boosts flow efficiency of particle accelerators May lead to smaller accelerators, easier to operate at reduced costs

Why are breast cancer survivors foregoing recommended screening? Study finds poor adherence to annual mammogram guidelines

Is low cost Proton-to-Carbon Heavy Ion radiotherapy coming soon? Best Particle Therapy plans to bring smaller footprint system to market in two to three years

Researchers develop AI approach for high-risk clinical tumor volumes Assisting low- and middle-income countries that lack contouring expertise

Maryland Proton Treatment Center

What factors impact the success of a proton therapy facility?

John W. Mitchell , Senior Correspondent
From the September 2017 issue of DOTmed HealthCare Business News magazine

As mounting evidence illustrates proton therapy’s value for cancer patients, the number of facilities offering the treatment continues to rise, but that doesn’t mean every proton therapy center is a success. Over the years, a few of these facilities – which can cost hundreds of millions of dollars to open – have been hit with financial hardships.

What distinguishes a thriving proton therapy facility from one that struggles to stay afloat? What kind of questions do providers need to ask before investing in this cutting-edge treatment?

Story Continues Below Advertisement

Breast Health Solutions

Innovative AI software solutions built on deep learning for breast tomosynthesis, breast density and 2D mammography. Learn more>



Earlier this year, the California Proton Treatment Center in San Diego filed for Chapter 11 bankruptcy. While the center has treated 1,400 patients since it opened a little more than three years ago, volumes have been less than expected. It seems fewer men with prostate cancer had been referred for treatment, according to a Scripps source who asked not to be identified.

ROTEUSPLUS is a multi-room proton therapy solution
with the latest advances in precise, imageguided
and intensity-modulated proton beam delivery.

"The treatment protocols for proton therapy for certain types of cancer, most notably prostate cancer, have become more conservative, making proton therapy more difficult to access for many patients," the source told HealthCare Business News via email. "Just a few months before Scripps Proton Therapy Center opened in February 2014, Blue Shield of California announced its plans to drop coverage for proton to treat early-stage prostate cancer."

The facility was built by an investment group and then leased to Scripps Health, which is not an investor or at financial risk in the arrangement.

This type of financial duress seems to be the exception to the norm, as new facilities continue to ramp up their own proton therapy centers. According to the National Association for Proton Therapy (NAPT), there are 25 proton centers operating in the U.S. (including two less than 20 miles apart in Oklahoma City) with another 11 centers in development. A recent analysis from Grand View Research projects the global proton therapy market will exceed $2.8 billion by 2025.
  Pages: 1 - 2 - 3 - 4 - ... >>

Oncology Homepage


You Must Be Logged In To Post A Comment

做广告
提升您的品牌知名度
拍卖+私人销售
获得最好的价格
买设备/配件
找到最低价格
每日新闻
阅读最新信息
目录
浏览所有的DOTmed用户
DOTmed上的伦理
查看我们的伦理计划
金子分开供营商节目
接收PH要求
金子服务经销商节目
接收请求
提供保健服务者
查看所有的HCP(简称医疗保健提供商)的工具
工作/训练
查找/申请工作
Parts Hunter +EasyPay
获取配件报价
最近证明
查看最近通过认证的用户
最近额定
查看最近通过认证的用户
出租中央
租用设备优惠
卖设备/配件
得到最划算
服务技术员论坛
查找帮助和建议
简单的征求建议书
获取设备报价
真正商业展览
查找对设备的服务
对这个站点的通入和用途是受期限和条件我们支配 法律公告 & 保密性通知
物产和业主对 DOTmed.com,公司 Copyright ©2001-2018 DOTmed.com, Inc.
版权所有